Eliem Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems.
Eliem Therapeutics stock last closed at $2.76, up 1.85% from the previous day, and has decreased 14.55% in one year. It has underperformed other stocks in the Biotechnology industry by 0.09 percentage points. Eliem Therapeutics stock is currently +17.95% from its 52-week low of $2.34, and -25.81% from its 52-week high of $3.72.
There are currently 27.57M shares of ELYM outstanding. The market capitalization of ELYM is $76.10M. In the last 24 hours, 3570 ELYM shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy ELYM shares.
Based on our research, eToro is the best brokerage. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro now.
Open eToro AccountNow that you've selected the right brokerage, the next step is to fill out some personal info so you can buy ELYM stock today.
Now that you have opened your account on investing apps, your next step is to transfer the money for your investment:
Watch the walkthrough below to see the process of transferring funds into your new investment account.
After you have decided on the best place to buy Eliem Therapeutics stock, it's critical to analyze their stock prior to investing, so you actually comprehend the risk and opportunity.
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on ELYM's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge ELYM's intrinsic value.
Using relative valuations ratios:
You can access more valuation research on ELYM's stock here.
You can dig deeper into what analysts are saying on the Eliem Therapeutics stock forecast page.
In the past year, executives and large shareholders at ELYM have bought more shares than they have sold.
Valerie Morisset, EVP RD AND CSO of ELYM, was the latest ELYM insider to buy. They bought $10.86 worth of ELYM stock on Sep 20, 2023.
Learn more about who owns ELYM shares here.
No, Eliem Therapeutics doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary order types:
Hit the Open button and eToro will execute your order.
If you require more help with investing in stocks on eToro, watch the helpful video below:
Now that you own some ELYM stock, you'll want to stay up-to-date on your stock purchase.
Create a watchlist to see the latest developments about your ELYM stock.
To summarize, here are the 6 steps for buying Eliem Therapeutics stock:
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Eliem Therapeutics, get started below.